Clinical Trial Update: Evaluating NeuroVision's Neural Vision Correction (NVC) Myopia Treatment [NA]

View source ↗

Summary

A terminated clinical trial evaluating NeuroVision's Neural Vision Correction for myopia with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myopia

Drugs mentioned

• Neural Vision Correction (NVC) (Neural Vision Correction)

Snippet

Sponsor: Ohio State University | Conditions: Myopia | NA | Status: TERMINATED | Results posted: 2018-09-25